Does RIPRETINIB Cause Hepatic neoplasm? 14 Reports in FDA Database

Q: Does RIPRETINIB cause Hepatic neoplasm?

14 reports of Hepatic neoplasm have been filed with the FDA for RIPRETINIB, representing 0.3% of all RIPRETINIB adverse event reports.

Q: How dangerous is Hepatic neoplasm from RIPRETINIB?

Of 14 reports, 2 (14.3%) resulted in death and 3 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hepatic neoplasm have been filed in association with RIPRETINIB (QINLOCK). This represents 0.3% of all adverse event reports for RIPRETINIB.

Reports of Hepatic neoplasm with RIPRETINIB

0.3%

of all RIPRETINIB reports

Deaths

Hospitalizations

How Dangerous Is Hepatic neoplasm From RIPRETINIB?

Of the 14 reports, 2 (14.3%) resulted in death, 3 (21.4%) required hospitalization.

Is Hepatic neoplasm Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does RIPRETINIB Cause?

Fatigue (582) Alopecia (517) Extra dose administered (357) Death (356) Underdose (345) Nausea (292) Drug ineffective (291) Disease progression (290) Hospitalisation (280) Neoplasm progression (263)

What Other Drugs Cause Hepatic neoplasm?

OCTREOTIDE (300) ADALIMUMAB (98) LANREOTIDE (85) EVEROLIMUS (84) AMLODIPINE (74) ROSUVASTATIN (55) IMATINIB (51) BEVACIZUMAB (49) RIBAVIRIN (49) METFORMIN (47)

Which RIPRETINIB Alternatives Have Lower Hepatic neoplasm Risk?

RIPRETINIB vs RISANKIZUMAB RIPRETINIB vs RISANKIZUMAB-RZAA RIPRETINIB vs RISDIPLAM RIPRETINIB vs RISEDRONATE RIPRETINIB vs RISEDRONIC ACID

RIPRETINIB Full Profile All Hepatic neoplasm Reports All Drugs Causing Hepatic neoplasm RIPRETINIB Demographics